Focus on precision health management of intestinal microecology
Company Introduction
Fojann is rooted at the forefront of microbiomics and immune regulation research. It has developed a dual-core technology platform driven by “multi-omics big data + AI-powered intelligent medicine,” which deeply integrates core technologies across three major domains: bioinformatics, artificial intelligence, and clinical medicine. Focused on microbial detection, precise immune system assessment, and effective intervention, Fojann delivers to global users a full-chain solution spanning from disease risk early screening to precision health management of the intestinal microecology. The R&D team is from top microbiology laboratories in the United States and Canada.
Focusing on Intestinal Microbiota
Known as the body’s “second genome,” the gut microbiota is a cornerstone of modern wellness and a paradigm of precision medicine. The balance of gut microbia critically influences the body’s metabolism, immunity, digestion, and even emotional and neurological health, making it key to maintaining overall vitality. At Fojann, we specialize in decoding this complex ecosystem. We provide both targeted 16S rRNA sequencing for large-scale community overviews and comprehensive metagenomic sequencing for in-depth species and functional analysis, allowing us to offer the optimal analytical depth for research or health assessment need.
Beyond sequencing, our core strength is our proprietary database and intelligent microbial platform. This system translates raw genetic data into actionable, in-depth insights. By analyzing an individual’s unique microbial signature, we deliver precise health and conditioning solutions tailored to different populations, turning complex data into a clear path toward personalized well-being.
Intelligent Microbial Application Platform
The Intelligent Microbial Application Platform is an advanced technological system integrating microbial research, data analysis, and practical applications. Leveraging AI, big data, and bioinformatics, it streamlines microbial screening, functional prediction, and personalized design.
Data-wise, it sources from 12 selected microbial databases (from 6047, screened for relevance, accessibility, etc.), extracts knowledge from 30 million+ PubTator3 – annotated biomedical literatures (with confidence scores), and uses a precision medicine knowledge base. The platform, built on MySQL, MongoDB, Neo4j, has broad data sources, complete development, rigorous logic (rooted in microbiology, etc.), and integrates search, Q&A, research, and more functions.
Comprehensive Probiotic Platform
The Comprehensive Probiotic Platform is a versatile initiative dedicated to developing diverse probiotic solutions. It encompasses a range of beneficial components, including Akkermansia muciniphila (AKK) — which is valued for its potential in supporting healthy metabolism and gut barrier function — as well as Clostridium Butyricum tailored for male health that utilize natural ingredients, along with supplement options like vitamins.
Leveraging these varied elements, the platform aims to formulate effective, viable probiotic-based products that cater to a wide spectrum of health needs. By integrating multiple probiotic strains and supplementary nutrients, it provides holistic support for overall wellness, moving beyond a singular focus to address diverse health requirements.
Fojann Bio-pharmaceuticals Limited (USA)
Address: 8 The Green, Ste A,Dover, Kent County,Delaware, 19901, USA
Email: fojann@fojann.com
Committed to cutting-edge microbial technology research
Continuously providing precision medicine solutions to the industry